11 guidelines, several studies and a few systematic reviews
comparing CEA and CAS have been reported, and the role of medical management has been reemphasized. In the present
publication, we have updated and expanded on the 2011 guidelines with speciﬁc emphasis on ﬁve areas: (1) is CEA recommended over maximal medical therapy for low-risk patients; (2) is CEA recommended over transfemoral CAS for low
surgical risk